Impaired fibrinolysis and risk of thromboembolism.
Wiman
B
B
Department of Clinical Chemistry, King Gustaf V Research Institute, Karolinska Hospital, Stockholm, Sweden.
Hamsten
A
A
D003327:Coronary Disease / Q000209:etiology*; D005342:Fibrinolysis / Q000502:physiology*; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology; D015849:Plasminogen Inactivators; D012307:Risk Factors; D013923:Thromboembolism / Q000209:etiology*; D010959:Tissue Plasminogen Activator / Q000502:physiology
D015849:Plasminogen Inactivators; D010959:Tissue Plasminogen Activator